DG Innovate PLC - Interim Results
DG Innovate plc
("DG Innovate", the "Company", or the "Group")
Interim results for the six months ended
DG Innovate (LSE: DGI), the advanced research and development company developing pioneering solutions in sustainable mobility and energy storage, announces the Company's unaudited interim results for the six months ended
Chief Executive's Report
We continued to make excellent progress on the development of our electric mobility and energy storage technologies during the first half of 2024. By the end of January we had highlighted the breadth of commercial opportunities for our Pareta® drive technology with the news that "Approval in Principle" had been received from Lloyd's Register for its use in marine vessels, as well as signing a Joint Development Agreement with a tier one commercial vehicle components company to jointly develop systems for heavy goods vehicles. Post period end, in July initial prototypes were delivered to the partner in the latter project, with our technical team now supporting testing at the partner's facility.
In March, we entered into a Memorandum of Understanding ("MoU") with EVage Automotive Pvt. Limited ("EVage"), an Indian electric vehicle maker and automotive technology company. Work continues to conclude the proposed establishment of the associated joint venture in
In May we raised
June saw a major shift within the Company's management team, as our founder and former CTO
We also welcomed Sir
We look forward to updating shareholders further in due course.
Chief Executive Officer
Financial Review
For the six months to
Cash flow
As at
For further information please contact:
|
DG Innovate plc |
C/O IFC |
|
|
|
|
IFC Advisory (Investor Relations) |
020 3934 6630 |
|
|
|
|
Grant Thornton UK LLP (Financial Adviser) |
020 7383 5100 |
|
|
|
|
Cavendish Capital Markets Limited (Corporate Broker)
|
020 7220 0500
|
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
FOR THE SIX MONTHS ENDED
|
|
Notes |
Six months ended 30 June |
Six months ended 30 June |
Year ended 31 December |
|
|
|
2024 |
2023 |
2023 |
|
|
|
Unaudited |
Unaudited |
Audited |
|
|
|
£ |
£ |
£ |
|
Revenue |
|
|
|
|
|
Turnover |
|
116,400 |
30,240 |
30,240 |
|
|
|
|
|
|
|
Cost of sales |
|
(88,771) |
(24,662) |
(19,729) |
|
|
|
|
|
|
|
Gross Profit |
|
27,629 |
5,578 |
10,511 |
|
|
|
|
|
|
|
Grant income |
|
250,623 |
399,641 |
618,021 |
|
Other income |
|
2,542 |
802 |
2,993 |
|
|
|
|
|
|
|
Administrative expenses |
3 |
(2,247,093) |
(1,734,306) |
(3,092,186) |
|
Share based payments |
|
(931,245) |
(564,292) |
(1,324,443) |
|
|
|
|
|
|
|
Operating loss |
|
(2,897,544) |
(1,892,577) |
(3,785,104) |
|
|
|
|
|
|
|
Finance income |
|
449 |
50 |
66 |
|
Finance cost |
|
(146,975) |
(15,726) |
(45,078) |
|
Other gains and losses |
|
- |
- |
(77,272) |
|
|
|
|
|
|
|
Loss on ordinary activities before taxation |
|
(3,044,070) |
(1,908,253) |
(3,907,388) |
|
|
|
|
|
|
|
Income tax |
|
- |
- |
131,443 |
|
|
|
|
|
|
|
Loss for the period and total comprehensive loss attributable to the equity holders |
|
(3,044,070) |
(1,908,253) |
(3,775,945) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share (pence) |
|
|
|
|
|
- Basic & diluted |
4 |
(0.029) |
(0.021) |
(0.04) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All operating income and operating gains and losses relate to continuing activities.
There was no other comprehensive income for the period (
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
FOR THE SIX MONTHS ENDED
|
|
Share Capital |
Share Premium |
Capital Redemption Reserve |
Reverse Acquisition Reserve (Restated*) |
Merger Reserve |
Share Option Reserve (Restated*)
|
CLNs Equity Reserve |
Retained earnings
|
Total |
|
Balance at |
9,311,948 |
31,998,163 |
8,783,824 |
(64,124,885) |
26,987,257 |
1,198,855 |
490,794 |
(10,266,313) |
4,379,643 |
|
Comprehensive income Loss for the period |
- |
- |
- |
- |
- |
- |
- |
(3,044,070) |
(3,044,070) |
|
Share based payments |
- |
- |
- |
- |
- |
931,245 |
- |
- |
931,245 |
|
|
|
|
|
|
|
|
|
|
|
|
Total Comprehensive loss |
- |
- |
- |
- |
- |
931,245 |
- |
(3,044,070) |
(2,112,825) |
|
|
|
|
|
|
|
|
|
|
|
|
Total contributions by and distributions to owners of the Group |
|
|
|
|
|
|
|
|
|
|
Issue of share capital net of issue costs |
80,770 |
657,358 |
- |
- |
- |
- |
- |
- |
738,128 |
|
|
|
|
|
|
|
|
|
|
|
|
As at |
9,392,718 |
32,655,521 |
8,783,824 |
(64,124,885) |
26,987,257 |
2,130,100 |
490,794 |
(13,310,383) |
3,004,946 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at |
8,842,715 |
31,518,134 |
8,783,824 |
(64,124,885) |
26,987,257 |
699,385 |
- |
(7,315,340) |
5,391,090 |
|
Comprehensive income Loss for the period |
- |
- |
- |
- |
- |
- |
- |
(3,775,945) |
(3,775,945) |
|
Share based payments |
- |
- |
- |
- |
- |
1,324,442 |
- |
- |
1,324,442 |
|
|
|
|
|
|
|
|
|
|
|
|
Total Comprehensive loss |
- |
- |
- |
- |
- |
1,324,442 |
- |
(3,775,945) |
(2,451,503) |
|
|
|
|
|
|
|
|
|
|
|
|
Total contributions by and distributions to owners of the Group |
|
|
|
|
|
|
|
|
|
|
Issue of share capital net of issue costs |
469,233 |
480,029 |
- |
- |
- |
- |
- |
- |
949,262 |
|
Issue of convertible loan notes |
- |
- |
- |
- |
- |
- |
490,794 |
- |
490,794 |
|
Reclassification of lapsed or cancelled share based payments |
- |
- |
- |
- |
- |
(824,972) |
- |
(824,972) |
- |
|
|
|
|
|
|
|
|
|
|
|
|
As at |
9,311,948 |
31,998,163 |
8,783,824 |
(64,124,885) |
26,987,257 |
1,198,855 |
490,794 |
(10,266,313) |
4,379,643 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at |
8,842,715 |
31,518,134 |
8,783,824 |
(64,124,885) |
26,987,257 |
699,385 |
- |
(7,315,340) |
5,391,090 |
|
Comprehensive income Loss for the period |
- |
- |
- |
- |
- |
- |
- |
(1,908,253) |
(1,908,253) |
|
Share based payments |
- |
- |
- |
- |
- |
564,292 |
- |
- |
564,292 |
|
|
|
|
|
|
|
|
|
|
|
|
Total Comprehensive loss |
- |
- |
- |
- |
- |
564,292 |
- |
(1,908,253) |
(1,343,961) |
|
|
|
|
|
|
|
|
|
|
|
|
Total contributions by and distributions to owners of the Group |
|
|
|
|
|
|
|
|
|
|
Issue of share capital net of issue costs |
365,833 |
187,985 |
- |
- |
- |
- |
- |
- |
553,818 |
|
|
|
|
|
|
|
|
|
|
|
|
As at |
9,208,548 |
31,706,119 |
8,783,824 |
(64,124,885) |
26,987,257 |
1,263,677 |
- |
(9,223,593) |
4,600,947 |
|
|
|
|
|
|
|
|
|
|
|
The Share Capital represents the nominal value of the equity shares. The Share Premium represents the amount subscribed for share capital, in excess of the nominal amount, less costs directly relating to the issue of shares.
The Share Option Reserve represents share-based payments which represents the cumulative fair value of options and warrants granted.
Reverse Acquisition Reserve and merger reserve were created due to the reverse acquisition of Deregallera Holdings Ltd.
*The comparative figures have been restated, refer to note 32 of the audited accounts for the year ended
CONSOLIDATED STATEMENT OF FINANCIAL POSITION
FOR THE SIX MONTHS ENDED
|
|
Notes |
As at 30 June |
As at 30 June |
As at 31 December |
|
|
|
2024 |
2023 (restated*) |
2023 |
|
|
|
Unaudited |
Unaudited |
Audited |
|
|
|
£ |
£ |
£ |
|
|
|
|
|
|
|
ASSETS |
|
|
|
|
|
Non-current assets |
|
|
|
|
|
Property, plant and equipment |
5 |
583,844 |
748,904 |
536,229 |
|
Intangible asset |
6 |
4,285,829 |
4,462,676 |
4,419,286 |
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
Trade and other receivables |
7 |
435,854 |
418,332 |
404,736 |
|
Cash and cash equivalents |
|
818,462 |
159,958 |
1,879,701 |
|
|
|
1,254,316
|
578,290
|
2,284,437 |
|
LIABILITIES |
|
|
|
|
|
Current liabilities |
|
|
|
|
|
Trade and other payables |
8 |
(766,565)
|
(667,872)
|
(564,864) |
|
Net Current Assets |
|
487,751 |
(89,582) |
1,719,573 |
|
|
|
|
|
|
|
Non-current liabilities |
9 |
(2,317,624) |
(489,481) |
(2,262,273) |
|
|
|
|
|
|
|
Provision for liabilities |
|
(34,854) |
(31,570) |
(33,172) |
|
|
|
|
|
|
|
NET ASSETS |
|
3,004,946 |
4,600,947 |
4,379,643 |
|
SHAREHOLDERS' EQUITY |
|
|
|
|
|
Called up share capital |
11 |
9,392,718 |
9,208,548 |
9,311,948 |
|
Capital redemption reserve |
|
8,783,824 |
8,783,824 |
8,783,824 |
|
Share premium account |
|
32,655,521 |
31,706,119 |
31,998,163 |
|
Share option reserve |
|
2,130,100 |
1,263,677 |
1,198,855 |
|
Merger reserve |
|
26,987,257 |
26,987,257 |
26,987,257 |
|
Reverse acquisition reserve |
|
(64,124,885) |
(64,124,885) |
(64,124,885) |
|
CLN equity reserve |
|
490,794 |
- |
490,794 |
|
Retained earnings |
|
(13,310,383) |
(9,223,593) |
(10,266,313) |
|
TOTAL EQUITY |
|
3,004,946 |
4,600,947 |
4,379,643 |
|
|
|
|
|
|
*The comparative figures as at
CONSOLIDATED STATEMENT OF CASH FLOWS
FOR THE SIX MONTHS ENDED
|
|
|
Six months to 30 June |
Six months to 30 June |
Year ended 31 December |
|
|
|
2024 |
2023 |
2023 |
|
|
|
Unaudited |
Unaudited |
Audited |
|
|
|
£ |
£ |
£ |
|
Loss for the period after tax |
|
(3,044,070) |
(1,908,253) |
(3,775,945) |
|
(Increase)/decrease in debtors |
|
(31,118) |
605,220 |
564,981 |
|
(Decrease)/increase in creditors within one year |
|
232,191 |
50,912 |
(6,999) |
|
Movement in provisions |
|
1,682 |
(1,524) |
3,126 |
|
Taxation |
|
- |
- |
(131,443) |
|
Share based payments |
|
931,245 |
564,292 |
1,324,443 |
|
Finance income |
|
(449) |
(50) |
- |
|
Finance costs |
|
146,975 |
15,726 |
45,076 |
|
Amortisation |
|
133,457 |
170,392 |
303,847 |
|
Depreciation |
|
59,480 |
63,435 |
125,678 |
|
Losses on disposal of fixed assets |
|
- |
- |
77,272 |
|
Tax refunded |
|
- |
92,578 |
165,213 |
|
Net cash (outflow) / inflow from operating activities |
|
(1,570,607) |
(347,272) |
(1,304,751) |
|
|
|
|
|
|
|
Cash flows from investing activities |
|
|
|
|
|
Proceeds from disposal of property, plant and equipment |
|
- |
- |
76,203 |
|
Purchase of property, plant and equipment |
|
(107,094) |
(87,248) |
(11,766) |
|
Purchase of intangible fixed assets |
|
- |
(59,476) |
(149,541) |
|
Finance income |
|
- |
50 |
- |
|
Finance cost |
|
- |
(15,726) |
- |
|
Net cash used in investing activities |
|
(107,094) |
(162,400)) |
(85,104) |
|
|
|
|
|
|
|
Cash flows from financing activities |
|
|
|
|
|
Finance income |
|
449 |
- |
- |
|
Finance cost |
|
(12,978) |
- |
(34,296) |
|
Issue of convertible loan notes |
|
- |
- |
2,431,000 |
|
Issue costs on convertible loan notes |
|
- |
- |
(102,892) |
|
Proceeds from issue of shares net of issue cost |
|
738,128 |
418,000 |
828,237 |
|
Repayment of borrowings |
|
(84,849) |
(40,620) |
(135,729) |
|
(Repayment)/increase of lease liabilities |
|
(24,288) |
57,260 |
(44,686) |
|
Proceeds from borrowings |
|
- |
- |
92,932 |
|
Net cash generated from financing activities |
|
616,462 |
434,640 |
3,034,566 |
|
|
|
|
|
|
|
Net increase/(decrease) in cash and cash equivalents |
|
(1,061,239) |
(75,032) |
1,644,711 |
|
Cash and cash equivalents at beginning of period |
|
1,879,701 |
234,990 |
234,990 |
|
Cash and cash equivalents at end of period |
|
818,462 |
159,958 |
1,879,701 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NOTES TO THE FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED
1. GENERAL INFORMATION
DG Innovate Plc is a public limited company incorporated in the United Kingdom, registered under company number 04006413. The address of the registered office is 15 Victoria Mews,
The consolidated financial information represents the results of DG Innovate Plc and its subsidiaries (together referred to as Group).
2. ACCOUNTING POLICIES
2.1 Basis of preparation
The condensed consolidated interim financial statements are presented in UK Sterling and all values are rounded to the nearest pound except where indicated otherwise.
The condensed consolidated interim financial statements have been prepared under the historical cost convention or fair value where appropriate.
The results for the six months to
During the period, there have been no changes in the nature of the related party transactions from those described in the Company's 2023 accounts.
2.2 Responsibility statement
The directors confirm that these condensed interim financial statements have been prepared in accordance with International Accounting Standard 34 "Interim Financial Reporting", as adopted by the United Kingdom and as issued by the IASB and that the interim management report includes a fair review of the information required by DTR 4.2.7R and DTR 4.2.8R, namely;
a) An indication of the important events that have occurred during the first six months and their impact on the condensed set of financial statements, and a description of the principal risks and uncertainties for the remaining six months of the financial year; and
b) Material related party transactions in the first six months and any material changes in related party transactions described in the last annual report.
2.3 Segmental reporting
The Group has two distinct areas of focus (Enhanced Drive Technology and Enhanced Battery Technology), and management have identified the Group's series of Pareta® electric drives and hard carbon anode materials as its two cash generating units (CGUs). However, as the Group is currently in the development phase and effectively operates as one operating unit under IFRS 8, segmental information is not available or presented within these accounts.
The aggregate value in use calculated for the two identified CGUs as at
2.4 Reverse acquisition
On
3. ADMINISTRATIVE EXPENSES
|
|
Six months to |
Six months to |
Year ended 31 December 2023 |
|
|
Unaudited |
Unaudited |
Audited |
|
|
£ |
£ |
£ |
|
Directors remuneration |
688,628 |
393,292 |
1,748,174 |
|
Other administrative expenses |
1,558,465 |
1,341,014 |
1,344,012 |
|
|
2,247,093 |
1,734,306 |
3,092,186 |
4. LOSS PER SHARE
The calculation of the basic and diluted loss per share is based on the loss on ordinary activities after taxation of and on the weighted average number of ordinary shares in issue.
There was no dilutive effect from the share options or convertible loan notes outstanding during the period.
In order to calculate the diluted earnings per share, the weighted average number of ordinary shares in issue is adjusted to assume conversion of all dilutive potential ordinary shares according to IAS33. Dilutive potential ordinary shares include convertible loan notes and share options granted to Directors and consultants where the exercise price (adjusted according to IAS33) is less than the average market price of the Company's ordinary shares during the period.
The weighted average number of shares is calculated using the number of DG Innovate Plc shares owned by the accounting acquirer DHL pre and post the reverse takeover on
|
|
Six months to |
Six months to |
Year ended 31 December 2023 |
|
|
Unaudited |
Unaudited |
Audited |
|
|
£ |
£ |
£ |
|
Net loss for the period |
(3,044,070) |
(1,908,253) |
(3,775,945) |
|
|
|
|
|
|
The weighted average number of shares in the period were: |
|
|
|
|
|
|
|
|
|
Basic and dilutive ordinary shares |
10,352,748,440 |
9,147,913,081 |
9,646,619,216 |
|
|
|
|
|
|
Basic and dilutive earnings/(loss) per share (pence) |
(0.029) |
(0.021) |
(0.04) |
5. PROPERTY, PLANT AND EQUIPMENT
|
|
Improvements to leasehold property |
Plant & equipment |
Right of use asset |
Total |
|
|
|
£ |
£ |
£ |
£ |
|
|
|
|
|
|
|
|
|
Cost |
|
|
|
|
|
|
At |
314,294 |
1,030,575 |
451,978 |
1,796,847 |
|
|
Additions |
28,273 |
78,821 |
- |
107,094 |
|
|
|
|
|
|
|
|
|
At |
342,567 |
1,109,396 |
451,978 |
1,903,941 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation |
|
|
|
|
|
|
Depreciation at |
314,294 |
850,265 |
96,058 |
1,260,617 |
|
|
Charge in the period |
1,745 |
29,268 |
28,467 |
59,480 |
|
|
|
|
|
|
|
|
|
Depreciation at |
316,039 |
879,533 |
124,525 |
1,320,097 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Carrying value |
|
|
|
|
|
|
At |
26,528 |
229,863 |
327,453 |
583,844 |
|
|
At |
- |
180,310 |
355,920 |
536,230 |
|
|
At |
- |
359,551 |
389,353 |
748,904 |
|
|
|
|
|
|
|
|
6. intangible ASSETS
|
|
IPR & Patents |
Total |
|
|
£ |
£ |
|
|
|
|
|
Cost |
|
|
|
At |
7,218,295 |
7,218,295 |
|
Additions |
- |
- |
|
|
|
|
|
At |
7,218,295 |
7,218,295 |
|
|
|
|
|
|
|
|
|
Amortisation |
|
|
|
Amortisation at |
2,799,009 |
2,799,009 |
|
Charge in the period |
133,455 |
133,455 |
|
|
|
|
|
Amortisation at 30 June 2024 |
2,932,464 |
2,932,464 |
|
|
|
|
|
|
|
|
|
Carrying value |
|
|
|
At 30 June 2024 |
4,285,831 |
4,285,831 |
|
At 31 December 2023 |
4,419,286 |
4,419,286 |
|
At 30 June 2023 |
4,462,676 |
4,462,676 |
On 8 April 2022 the Company completed the reverse takeover and acquired 100% of the ordinary share capital of Deregallera Holdings Ltd, a company incorporated in England and Wales.
No impairment has been accounted for this interim period. An impairment review will be carried out at the year end.
7. TRade and other RECEIVABLES
|
|
As at 30 June 2024 |
As at 30 June 2023 |
As at 31 December 2023 |
|
|
Unaudited |
Unaudited |
Audited |
|
|
£ |
£ |
£ |
|
|
|
|
|
|
Trade receivables |
2,166 |
- |
- |
|
Prepayments |
61,012 |
69,811 |
120,968 |
|
Other taxes and social security |
223,696 |
260,889 |
168,695 |
|
Other debtors |
148,980 |
87,632 |
115,073 |
|
|
435,854 |
418,332 |
404,736 |
Also included in other debtors are amounts repayable of £87,369 (30 June 2023: £87,369; 31 December 2023: £87,369) by certain Directors in respect of incorrectly awarded bonuses.
Other taxes and social security comprise the R&D tax credit, tax suffered on the bonuses noted above and VAT repayable.
8. TRade and other payables
|
|
As at 30 June 2024 |
As at 30 June 2023 |
As at 31 December 2023 |
|
|
Unaudited |
Unaudited |
Audited |
|
|
£ |
£ |
£ |
|
|
|
|
|
|
Trade payables |
254,793 |
190,961 |
91,724 |
|
Accruals and deferred income |
307,669 |
188,241 |
233,221 |
|
Loans and other borrowings |
97,679 |
87,679 |
132,786 |
|
Lease liabilities |
75,803 |
74,548 |
75,166 |
|
Other creditors |
30,621 |
126,443 |
31,967 |
|
|
766,565 |
667,872 |
564,864 |
9. non-current liabilities
|
|
As at 30 June 2024 |
As at 30 June 20223 |
As at 31 December 2023 |
|
|
Unaudited |
Unaudited |
Audited |
|
|
£ |
£ |
£ |
|
|
|
|
|
|
Convertible loan notes (note 10) |
1,982,092 |
- |
1,848,094 |
|
Other loans and other borrowings |
43,417 |
140,442 |
93,159 |
|
Lease liabilities |
280,030 |
328,994 |
304,955 |
|
Other creditors |
12,085 |
20,045 |
16,065 |
|
|
2,317,624 |
489,481 |
2,262,273 |
10. convertible loan notes
On 11 December 2023, the Company authorised the issue of £2,431,000 in convertible loan notes ("CLNs"). The CLNs have no coupon and are convertible into the Company's ordinary shares of 0.01 pence at a price of 0.035 pence per share. They are convertible (i) after one year, subject to the availability of a valid exemption from the requirement to prepare a prospectus in respect of the Ordinary Shares arising from the conversion; or (ii) following admission of the Company's ordinary share capital to the AIM Market of the London Stock Exchange.
|
|
As at 30 June 2024 |
As at 30 June 20223 |
As at 31 December 2023 |
|
|
Unaudited |
Unaudited |
Audited |
|
|
£ |
£ |
£ |
|
|
|
|
|
|
Equity element |
490,794 |
- |
490,794 |
|
Liability element |
1,848,094 |
- |
1,837,314 |
|
Interest charge in the period |
133,998 |
- |
10,780 |
|
|
2,472,886 |
- |
2,338,888 |
11. SHARE Capital
|
|
|
|
|
|
Allotted, called up and fully paid |
|
|
|
|
|
|
Ordinary Shares of 0.1p each |
|
|
|
|
No |
£ |
|
|
|
|
|
|
|
|
|
|
|
At 1 January 2023 |
|
8,842,715,107 |
8,842,715 |
|
Issue of shares |
|
365,833,333 |
365,833 |
|
At 18 July 2023 |
|
9,208,548,440 |
9,208,548 |
|
Subdivided 0.1p each Ordinary Shares* |
|
|
|
|
|
|
Share Capital |
|
|
|
|
No |
£ |
|
|
|
|
|
|
|
|
|
|
|
At 19 July 2023 |
|
|
|
|
0.01p each Ordinary Shares |
|
9,208,548,440 |
920,854 |
|
0.09p each Deferred Shares** |
|
9,208,548,440 |
8,287,694 |
|
Issue of Ordinary Shares of 0.01p each |
|
1,034,000,000 |
103,400 |
|
At 31 December 2023 |
|
19,451,096,880 |
9,311,948 |
|
|
|
Share Capital |
|
|
|
|
No |
£ |
|
|
|
|
|
|
At 1 January 2024 |
|
|
|
|
0.01p each Ordinary Shares |
|
10,242,548,440 |
1,024,254 |
|
0.09p each Deferred Shares |
|
9,208,548,440 |
8,287,694 |
|
Issue of Ordinary Shares of 0.01p each |
|
807,700,000 |
80,770 |
|
At 30 June 2024 |
|
20,258,796,880 |
9,392,718 |
*Resolution was passed on 19 July 2023 to subdivide one 0.1p Ordinary Share into one 0.01p Ordinary Share and one 0.09 Deferred Share.
** The deferred shares have no economic rights and therefore have been excluded from earnings per share calculation.
12. share options and warrants
Movement in the number of options and warrants outstanding and their related weighted average exercise price, since 31 December 2023 are as follows:
|
|
At 30 June 2024 |
At 30 June 2023 |
At 31 December 2023 |
|
||||||
|
|
Number of Options & Warrants
|
Weighted average exercise price per share |
Number of Options & Warrants
|
Weighted average exercise price per share |
Number of Options & Warrants
|
Weighted average exercise price per share |
||||
|
At 1 January |
10,298,584,962 |
0.08p |
3,937,526,910 |
0.33p |
3,937,526,910 |
0.33p |
||||
|
Granted |
500,000,000 |
0.01p |
368,333,333 |
0.18p |
7,625,747,619 |
0.04p |
||||
|
Exercised |
(21,200,000) |
0.10p |
- |
- |
- |
- |
||||
|
Modified |
- |
- |
- |
- |
(156,105,002) |
- |
||||
|
Expired or waived |
(2,429,823,984) |
0.17p |
(3,975,633) |
0.10p |
(1,108,584,565) |
0.10p |
||||
|
At period end |
8,347,560,978 |
0.09p |
4,301,884,610 |
0.16p |
10,298,584,962 |
0.08p |
||||
The following share options have been granted by the Company and are outstanding as at the period end of 30 June 2024:
|
Date of grant |
Number of ordinary shares under option at 1 January 2023 |
Granted during period |
Exercised during period |
Lapsed/ waived during period |
Number of ordinary shares under option at 30 June 2023 |
Weighted average exercise price |
Expiry date |
|
30/03/2017 |
4,000,000 |
- |
- |
- |
4,000,000 |
0.1p |
29/03/2027 |
|
30/03/2017 |
5,875,000 |
- |
- |
- |
5,875,000 |
1.0p |
29/03/2027 |
|
30/03/2017 |
2,937,500 |
- |
- |
- |
2,937,500 |
2.0p |
29/03/2027 |
|
18/03/2021 |
638,965,001 |
- |
- |
- |
638,965,001 |
0.1p |
07/10/2030 |
|
08/04/2022 |
320,616,397 |
- |
- |
(4,648,164) |
315,968,233 |
0.1p |
18/03/2031 |
|
12/10/2022 |
264,803,145 |
- |
- |
- |
264,803,145 |
0.1p |
13/04/2032 |
|
11/12/2023 |
6,000,000,000 |
- |
- |
(497,267,760) |
5,502,732,240 |
0.03p |
10/12/2033 |
|
11/12/2023 |
1,000,000,000 |
- |
- |
(497,267,760) |
502,732,240 |
0.06p |
10/12/2033 |
|
10/06/2024 |
- |
500,000,000 |
- |
- |
500,000,000 |
0.10p |
09/06/2027 |
|
Total |
8,237,197,043 |
500,000,000 |
- |
(999,183,684) |
7,738,013,359 |
0.05p |
|
All options outstanding at the period end are exercisable at that date.
The following warrants have been granted by the Company:
|
Date of grant |
Number of warrants at 1 January 2023 |
Granted during period |
Exercised during period |
Lapsed during period |
Number of warrants at 30 June 2023 |
Weighted average exercise price |
Expiry date |
|
18/03/2021 |
790,000,000 |
- |
- |
(790,000,000) |
- |
0.25p |
07/04/2024 |
|
08/04/2022 |
645,640,300 |
- |
(5,000,000) |
(640,640,300) |
- |
0.25p |
07/04/2024 |
|
23/01/2023 |
368,333,333 |
- |
- |
|
368,333,333 |
0.18p |
30/01/2025 |
|
19/07/2023 |
51,700,000 |
- |
(16,200,000) |
- |
35,500,000 |
0.05p |
21/07/2024 |
|
11/12/2023 |
205,714,286 |
- |
- |
- |
205,714,286 |
0.18p |
10/12/2024 |
|
10/06/2024 |
- |
500,000,000 |
- |
- |
500,000,000 |
0.10p |
09/06/2024 |
|
Total |
2,061,387,919 |
500,000,000 |
(21,2000,000) |
(1,430,640,300) |
1,109,547,619 |
0.11p |
|
In June 2024 the Company appointed Pierre Pellerey as Chief Technical Officer and granted him 500,000,000 warrants at an exercise price of 0.1 pence.
The fair value of equity settled share options and warrants granted is estimated at the date of grant using a Black-Scholes option pricing model, taking into account the terms and conditions upon which the options were granted. The following table lists the inputs to the model:
|
|
Warrants |
Warrants |
Options |
Options |
Options |
Warrants |
||||||
|
Date of grant/variation Expected volatility Expected life Risk-free interest rate Expected dividend yield Possibility of ceasing employment before vesting Fair value per option/warrant |
18 Mar 2021 70% 10 years 3.40% - -
0.005p |
08 Apr 2022 70% 10 years 3.40% - -
0.005p |
30 Jan 2023 70% 1.6 years 3.40% - -
0.022p |
21 Jul 2023 70% 10 years 4.40% - -
0.011p
|
11 Dec 2023 70% 10 years 3.40% - -
0.032p
|
10 Jun 2024 96% 3 years 4.10% - -
0.054p |
||||||
|
|
|
|
|
|
|
|
||||||
The expense recognised by the Group for share based payments during the period ended 30 June 2024 was £931,245, (30 June 2023: £564,292; 31 December 2023: £1,324,443).
The average volatility is used in determining the share based payment expense to be recognised in the period. This was calculated by reference to the standard deviation of the share price over the preceding 6-month period.
13. related party transactions
Share Options
The following share options were held by the active directors during the period:
|
Director |
Date of grant |
Held at 1 January 2024 |
Surrendered/ lapsed during the period |
Granted during the period |
Held at 30 June 2024 |
Exercise price |
|
J Allardyce |
18/03/2021 |
62,500,000 |
- |
- |
62,500,000 |
£0.001 |
|
|
08/04/2022 |
156,105,002 |
- |
- |
156,105,002 |
£0.001 |
|
P Tierney |
12/10/2022 |
264,803,145 |
- |
- |
264,803,145 |
£0.001 |
|
M Boughtwood |
11/12/2023 |
1,000,000,000 |
(497,267,760) |
- |
502,732,240 |
£0.0003 |
|
|
11/12/2023 |
1,000,000,000 |
(497,267,760) |
- |
502,732,240 |
£0.0006 |
|
C Eidem |
11/12/2023 |
2,000,000,000 |
- |
- |
2,000,000,000 |
£0.0003 |
|
P Bardenfletch-Hansen |
11/12/2023 |
1,500,000,000 |
- |
- |
1,500,000,000 |
£0.0003 |
|
J Rudat |
11/12/2023 |
1,500,000,000 |
- |
- |
1,500,000,000 |
£0.0003 |
|
Total |
|
7,483,408,147 |
(994,535,520) |
- |
6,488,872,627 |
|
Transaction with related party
During the period Gareth Boughtwood (son of Martin Boughtwood, an ex-director in the Group) was paid £723 (30 June 2023: £Nil; 31 December 2023: £1,196) in respect of IT services.
Other debtors
Included in other debtors are balances due from the following Directors, and former Directors, in respect of bonuses incorrectly awarded in 2022 and deemed to be held in trust. Chris Theis £87,369 (30 June 2023: £87,369; 31 December 2023: £87,369).
14. POST PERIOD EVENT
In September 2024 the Company raised gross proceeds of £550,000 via a placing of new ordinary shares with new and existing investors, and a further £67,275 from a retail offer to existing shareholders. The total number of new shares issued was 823,034,007 at a price of 0.075p each, with a further 28,035,840 shares issued at the same price to cover certain liabilities due to a creditor. In addition, the Company announced that certain members of its management team intend to subscribe for, in aggregate, £200,000 through a subscription at the same issue price. This was subject to the publication of the Company's 2024 interim accounts and the end of the associated closed period under UK MAR, and to the relevant individuals not being in possession of any other unpublished price sensitive information at such time.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE